• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双价 VSV 载体介导仓鼠对安第斯病毒挑战的快速和有效保护。

Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters.

机构信息

Laboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.

Department of Biomedical and Pharmaceutical Sciences, The University of Montana, Missoula, MT 59812, USA.

出版信息

Viruses. 2024 Feb 11;16(2):279. doi: 10.3390/v16020279.

DOI:10.3390/v16020279
PMID:38400054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10893017/
Abstract

Orthohantaviruses may cause hemorrhagic fever with renal syndrome or hantavirus cardiopulmonary syndrome. Andes virus (ANDV) is the only orthohantavirus associated with human-human transmission. Therefore, emergency vaccination would be a valuable public health measure to combat ANDV-derived infection clusters. Here, we utilized a promising vesicular stomatitis virus (VSV)-based vaccine to advance the approach for emergency applications. We compared monovalent and bivalent VSV vectors containing the Ebola virus (EBOV), glycoprotein (GP), and ANDV glycoprotein precursor (GPC) for protective efficacy in pre-, peri- and post-exposure immunization by the intraperitoneal and intranasal routes. Inclusion of the EBOV GP was based on its favorable immune cell targeting and the strong innate responses elicited by the VSV-EBOV vaccine. Our data indicates no difference of ANDV GPC expressing VSV vectors in pre-exposure immunization independent of route, but a potential benefit of the bivalent VSVs following peri- and post-exposure intraperitoneal vaccination.

摘要

正汉坦病毒可引起肾综合征出血热或汉坦病毒心肺综合征。安第斯病毒(ANDV)是唯一与人际传播相关的正汉坦病毒。因此,紧急接种疫苗将是对抗 ANDV 衍生感染群的宝贵公共卫生措施。在这里,我们利用有前途的水疱性口炎病毒(VSV)为基础的疫苗来推进紧急应用的方法。我们比较了单价和双价 VSV 载体,其中包含埃博拉病毒(EBOV)、糖蛋白(GP)和 ANDV 糖蛋白前体(GPC),通过腹腔内和鼻内途径进行暴露前、暴露中和暴露后免疫的保护效力。包含 EBOV GP 是基于其对免疫细胞的良好靶向性和 VSV-EBOV 疫苗引起的强烈先天反应。我们的数据表明,无论途径如何,暴露前免疫中表达 ANDV GPC 的 VSV 载体没有差异,但双价 VSV 在暴露后腹腔内接种后具有潜在的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a409/10893017/5bc218362ecc/viruses-16-00279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a409/10893017/87d4ea81c792/viruses-16-00279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a409/10893017/5bc218362ecc/viruses-16-00279-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a409/10893017/87d4ea81c792/viruses-16-00279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a409/10893017/5bc218362ecc/viruses-16-00279-g002.jpg

相似文献

1
Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters.双价 VSV 载体介导仓鼠对安第斯病毒挑战的快速和有效保护。
Viruses. 2024 Feb 11;16(2):279. doi: 10.3390/v16020279.
2
Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.基于水疱性口炎病毒的疫苗可保护仓鼠免受安第斯病毒的致死性攻击。
J Virol. 2011 Dec;85(23):12781-91. doi: 10.1128/JVI.00794-11. Epub 2011 Sep 14.
3
Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection.两价重组水疱性口炎病毒疫苗在致死性埃博拉病毒感染叙利亚仓鼠模型中的保护效力。
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1090-7. doi: 10.1093/infdis/jir379.
4
Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.非人类灵长类动物经肌肉注射而非鼻腔内接种一剂基于水疱性口炎病毒的疫苗可快速预防 COVID-19。
mBio. 2022 Feb 22;13(1):e0337921. doi: 10.1128/mbio.03379-21. Epub 2022 Jan 11.
5
Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.基于水疱性口炎病毒的安第斯病毒疫苗在叙利亚仓鼠中的长期单剂量疗效。
Viruses. 2014 Jan 31;6(2):516-23. doi: 10.3390/v6020516.
6
Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.豚鼠中增殖受限的水疱性口炎病毒编码埃博拉病毒糖蛋白的免疫原性。
J Gen Virol. 2018 Jul;99(7):866-879. doi: 10.1099/jgv.0.001085. Epub 2018 Jun 5.
7
Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques.基于水疱性口炎病毒的苏丹病毒疫苗的种属特异性免疫原性和保护效力:猕猴挑战研究。
Lancet Microbe. 2023 Mar;4(3):e171-e178. doi: 10.1016/S2666-5247(23)00001-0. Epub 2023 Feb 2.
8
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission.高剂量水疱性口炎病毒载体埃博拉病毒疫苗可引起猪的水疱病,但不会发生水平传播。
Emerg Microbes Infect. 2021 Dec;10(1):651-663. doi: 10.1080/22221751.2021.1903343.
9
Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory.建立和应用在二级生物安全实验室中人类埃博拉病毒病的替代模型。
Virol Sin. 2024 Jun;39(3):434-446. doi: 10.1016/j.virs.2024.03.010. Epub 2024 Mar 29.
10
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.VSV-EBOV 疫苗接种诱导的抗病毒先天免疫反应有助于快速保护。
mBio. 2019 May 28;10(3):e00597-19. doi: 10.1128/mBio.00597-19.

引用本文的文献

1
Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems.使用真实病毒和重组水疱性口炎病毒系统评估汉坦病毒感染患者的中和抗体
Viruses. 2025 May 19;17(5):723. doi: 10.3390/v17050723.

本文引用的文献

1
Presence and Persistence of Andes Virus RNA in Human Semen.安第斯病毒 RNA 在人精液中的存在与持续
Viruses. 2023 Nov 17;15(11):2266. doi: 10.3390/v15112266.
2
Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody.广谱汉坦病毒中和抗体的结构与作用机制基础
Sci Transl Med. 2023 Jun 14;15(700):eadg1855. doi: 10.1126/scitranslmed.adg1855.
3
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.单克隆抗体治疗产生的 SARS-CoV-2 逃逸突变。
Nat Commun. 2023 Jun 7;14(1):3334. doi: 10.1038/s41467-023-37826-w.
4
Hantavirus in humans: a review of clinical aspects and management.人感染汉坦病毒:临床方面和治疗的综述。
Lancet Infect Dis. 2023 Sep;23(9):e371-e382. doi: 10.1016/S1473-3099(23)00128-7. Epub 2023 Apr 24.
5
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies.抗原作图和人类新型布尼亚病毒中和抗体的功能特性鉴定。
Elife. 2023 Mar 27;12:e81743. doi: 10.7554/eLife.81743.
6
Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.人源抗体识别普马拉病毒糖蛋白上的四元表位,为抗正布尼亚病毒提供广泛保护。
Sci Transl Med. 2022 Mar 16;14(636):eabl5399. doi: 10.1126/scitranslmed.abl5399.
7
Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector.水泡性口炎病毒:从农业病原体到疫苗载体
Pathogens. 2021 Aug 27;10(9):1092. doi: 10.3390/pathogens10091092.
8
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment.先前接种 rVSV-ZEBOV 不会干扰但会提高暴露后抗体治疗的效果。
Nat Commun. 2020 Jul 27;11(1):3736. doi: 10.1038/s41467-020-17446-4.
9
A tool with many applications: vesicular stomatitis virus in research and medicine.一种用途广泛的工具:水泡性口炎病毒在研究和医学中的应用。
Expert Opin Biol Ther. 2020 Oct;20(10):1187-1201. doi: 10.1080/14712598.2020.1787981. Epub 2020 Jul 9.
10
Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.针对安第斯病毒糖蛋白刺突复合物的 Gn 和 Gc 的中和单克隆抗体可在临床前仓鼠模型中预防病毒挑战。
mBio. 2020 Mar 24;11(2):e00028-20. doi: 10.1128/mBio.00028-20.